Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, November 7, 2011

Upgrades and Downgrades Daily Report: (TSL), (DGX), (TSL), (CVS)

Trina Solar (TSL) is currently being analyzed by the brokerage firm Brigantine. They have just decreased their rating from Buy to Hold. This indicates that the company may not be doing as well as investors were expecting. Look for potential selling pressure or a downside move in the share price. Shares of TSL fell by 2.97% or $-0.24/share to $7.84. In the past year, the shares have traded as low as $5.56 and as high as $31.89. On average, 3644210 shares of TSL exchange hands on a given day and today's volume is recorded at 1640216.

RBC Capital Mkts, the brokerage firm, has recently increased the rating on Quest Diagnostics (DGX). They upped the rating from Sector Perform to Outperform. The brokerage firm believes the company may be on the upswing and there could be potential value in buying the stock. The target price is currently set at $68 per share by the brokerage firm. Shares of DGX traded higher by 1.58% or $0.88/share to $56.70. In the past year, the shares have traded as low as $45.77 and as high as $61.21. On average, 1991390 shares of DGX exchange hands on a given day and today's volume is recorded at 885489.

Trina Solar (TSL) recently had their rating decreased from Buy to Sell. Maxim Group is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bearish sign for the stock, and this brokerage house may tell its clients to sell the stock. The share prices may fall because of this action. Analysts believe that the company's share price may begin to fall. The target price is currently set at $5 per share by the brokerage firm. Shares of TSL fell by 2.97% or $-0.24/share to $7.84. In the past year, the shares have traded as low as $5.56 and as high as $31.89. On average, 3644210 shares of TSL exchange hands on a given day and today's volume is recorded at 1640216.

RBC Capital Mkts, the brokerage firm, has recently changed the rating on CVS Caremark (CVS). They upped the rating from Sector Perform to Outperform. The brokerage firm believes the company may be on the upswing and there could be potential value in buying the stock. The target price is currently set at $44 per share by the brokerage firm. Shares of CVS traded higher by 0.55% or $0.21/share to $38.23. In the past year, the shares have traded as low as $29.45 and as high as $39.50. On average, 10657700 shares of CVS exchange hands on a given day and today's volume is recorded at 6961910.